Clinical Trial Update: TiLE (Time Lapse Eeva) Clinical Trial [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for TiLE (Time Lapse Eeva) sponsored by Merck KGaA; study on fertility has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• TiLE (Time Lapse Eeva)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Fertility | Phase 4 | Status: COMPLETED | Results posted: 2019-04-29